Table 2 SRM transitions of fatty acid metabolites.

From: Omega-3 fatty acid prevents the development of heart failure by changing fatty acid composition in the heart

ARA metabolites

DHA metabolites

EPA metabolites

Compound

SRM transition (m/z)

Compound

SRM transition (m/z)

Compound

SRM transition (m/z)

ARA

303 > 259

DHA

327 > 283

EPA

301 > 257

PGE2

351 > 271

7-HDoHE

343 > 141

5-HEPE

317 > 115

PGD2

351 > 271

10-HDoHE

343 > 153

12-HEPE

317 > 179

PGF2α

353 > 193

13-HDoHE

343 > 193

15-HEPE

317 > 219

Iso-PGF2α

353 > 193

14-HDoHE

343 > 205

18-HEPE

317 > 259

5-HETE

319 > 115

17-HDoHE

343 > 245

RvE1

349 > 195

12-HETE

319 > 179

PD1

359 > 153

RvE2

333 > 115

15-HETE

319 > 219

RvD1

375 > 141

RvE3

333 > 213

TXB2

369 > 169

RvD2

375 > 175

PGD3

349 > 233

LTB4

335 > 195

  

TXB3

367 > 169

LXA4

351 > 115

    

ARA-d8

311 > 267

    

PGE2-d4

355 > 275

    

PGD2-d4

355 > 275

    

PGF2α-d4

357 > 197

    

5-HETE-d8

327 > 116

    
  1. PG prostaglandin, HETE hydroxyeicosatetraenoic acid, TX Thromboxane, LT leukotriene, LX Lipoxin, HDoHE hydroxydocosahexaenoic acid, PD Protectin D, Rv Resolvin, HEPE hydroxyeicosapentaenoic acids.
Back to article page